• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸肽分析揭示了与帕金森病相关蛋白激酶 LRRK2 的 N 端和 Roc 结构域中两个离散的磷酸化簇。

Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.

机构信息

Helmholtz Zentrum München-German Research Center for Environmental Health, Department of Protein Science, Neuherberg, Germany.

出版信息

J Proteome Res. 2010 Apr 5;9(4):1738-45. doi: 10.1021/pr9008578.

DOI:10.1021/pr9008578
PMID:20108944
Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) that increase its kinase activity associate with familial forms of Parkinson disease (PD). As phosphorylation determines the functional state of most protein kinases, we systematically mapped LRRK2 phosphorylation sites by mass spectrometry. Our analysis revealed a high degree of constitutive phosphorylation in a narrow serine-rich region preceding the LRR-domain. Allowing de novo autophosphorylation of purified LRRK2 in an in vitro autokinase assay prior to mass spectrometric analysis, we discovered multiple sites of autophosphorylation. Solely serine and threonine residues were found phosphorylated suggesting LRRK2 as a true serine threonine kinase. Autophosphorylation mainly targets the ROC GTPase domain and its clustering around the GTP binding pocket of ROC suggests cross-regulatory activity between kinase and Roc domain. In conclusion, the phosphoprotein LRRK2 functions as an autocatalytically active serine threonine kinase. Clustering of phosphosites within two discrete domains suggest that phosphorylation may regulate its biological functions in a yet unknown fashion.

摘要

富含亮氨酸重复激酶 2(LRRK2)中的突变会增加其激酶活性,并与家族性帕金森病(PD)相关。由于磷酸化决定了大多数蛋白激酶的功能状态,我们通过质谱法系统地绘制了 LRRK2 的磷酸化位点图。我们的分析揭示了在 LRR 结构域之前的一个狭窄的富含丝氨酸区域中存在高度的组成性磷酸化。在进行质谱分析之前,允许纯化的 LRRK2 在体外自激酶测定中从头进行自身磷酸化,我们发现了多个自身磷酸化位点。仅发现丝氨酸和苏氨酸残基被磷酸化,这表明 LRRK2 是一种真正的丝氨酸苏氨酸激酶。自身磷酸化主要靶向 ROC GTPase 结构域,并且 ROC 的 GTP 结合口袋周围的聚集表明激酶和 Roc 结构域之间存在交叉调节活性。总之,磷酸化蛋白 LRRK2 作为自身催化活性的丝氨酸苏氨酸激酶发挥作用。两个离散结构域内磷酸化位点的聚集表明,磷酸化可能以未知的方式调节其生物学功能。

相似文献

1
Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.磷酸肽分析揭示了与帕金森病相关蛋白激酶 LRRK2 的 N 端和 Roc 结构域中两个离散的磷酸化簇。
J Proteome Res. 2010 Apr 5;9(4):1738-45. doi: 10.1021/pr9008578.
2
Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation.LRRK2 自身磷酸化的系统分析揭示家族性帕金森病突变的差异效应。
Biochemistry. 2013 Sep 3;52(35):6052-62. doi: 10.1021/bi400596m. Epub 2013 Aug 23.
3
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.导致帕金森病的LRRK2突变I2020T与激酶活性增加有关。
Hum Mol Genet. 2006 Jan 15;15(2):223-32. doi: 10.1093/hmg/ddi439. Epub 2005 Dec 1.
4
Identification of the autophosphorylation sites of LRRK2.亮氨酸丰富重复激酶2(LRRK2)自磷酸化位点的鉴定
Biochemistry. 2009 Nov 24;48(46):10963-75. doi: 10.1021/bi9011379.
5
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.帕金森病激酶LRRK2在多个位点使其GTPase结构域发生自磷酸化。
Biochem Biophys Res Commun. 2009 Nov 20;389(3):449-54. doi: 10.1016/j.bbrc.2009.08.163. Epub 2009 Sep 3.
6
LRRK2 autophosphorylation enhances its GTPase activity.富含亮氨酸重复激酶2(LRRK2)的自磷酸化增强其GTP酶活性。
FASEB J. 2016 Jan;30(1):336-47. doi: 10.1096/fj.15-277095. Epub 2015 Sep 22.
7
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities.富含亮氨酸重复激酶 2(LRRK2)GTP 酶结构域中的自身磷酸化修饰激酶和 GTP 结合活性。
J Mol Biol. 2011 Sep 9;412(1):94-110. doi: 10.1016/j.jmb.2011.07.033. Epub 2011 Jul 22.
8
Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.富含亮氨酸重复激酶2(LRRK2)/PARK8具有GTP酶活性,该活性在家族性帕金森病R1441C/G突变体中发生改变。
J Neurochem. 2007 Oct;103(1):238-47. doi: 10.1111/j.1471-4159.2007.04743.x. Epub 2007 Jul 10.
9
Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.富含亮氨酸重复序列激酶2的富含亮氨酸重复序列同名结构域的表达、纯化及初步生化和结构表征
Biochim Biophys Acta. 2012 Mar;1824(3):450-60. doi: 10.1016/j.bbapap.2011.12.009. Epub 2012 Jan 11.
10
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease.GTP结合对于LRRK2的蛋白激酶活性至关重要,LRRK2是家族性帕金森病的致病基因产物。
Biochemistry. 2007 Feb 6;46(5):1380-8. doi: 10.1021/bi061960m.

引用本文的文献

1
14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state.14-3-3蛋白结合可使帕金森相关激酶LRRK2维持在非活性状态。
Nat Commun. 2025 Aug 5;16(1):7226. doi: 10.1038/s41467-025-62337-1.
2
Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism.通过一种依赖LRRK2激酶的机制对LRRK2 Roc G结构域进行分子内反馈调节。
Elife. 2024 Dec 19;12:RP91083. doi: 10.7554/eLife.91083.
3
RedOx regulation of LRRK2 kinase activity by active site cysteines.活性位点半胱氨酸对LRRK2激酶活性的氧化还原调节。
NPJ Parkinsons Dis. 2024 Apr 3;10(1):75. doi: 10.1038/s41531-024-00683-5.
4
Role of the leucine-rich repeat protein kinase 2 C-terminal tail in domain cross-talk.富含亮氨酸重复蛋白激酶 2 C 端尾部在结构域串扰中的作用。
Biochem J. 2024 Feb 21;481(4):313-327. doi: 10.1042/BCJ20230477.
5
Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson's disease related transcriptional profile and function.携带 LRRK2-G2019S 突变的人诱导多能干细胞源性小胶质细胞显示出帕金森病相关的转录谱和功能。
Sci Rep. 2023 Dec 13;13(1):22118. doi: 10.1038/s41598-023-49294-9.
6
Leucine-rich repeat kinase 2 at a glance.富含亮氨酸重复激酶 2 速览。
J Cell Sci. 2023 Sep 1;136(17). doi: 10.1242/jcs.259724. Epub 2023 Sep 12.
7
LRRK2 and Proteostasis in Parkinson's Disease.LRRK2 与帕金森病中的蛋白稳态
Int J Mol Sci. 2022 Jun 18;23(12):6808. doi: 10.3390/ijms23126808.
8
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.磷酸化位点突变方法研究 LRRK2,分别将磷酸化和去磷酸化与保护和有害标记联系起来。
Cells. 2022 Mar 17;11(6):1018. doi: 10.3390/cells11061018.
9
Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2.纳米抗体作为帕金森病相关 LRRK2 的别构调节剂。
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). doi: 10.1073/pnas.2112712119.
10
Structural analysis of the full-length human LRRK2.全长人 LRRK2 的结构分析。
Cell. 2021 Jun 24;184(13):3519-3527.e10. doi: 10.1016/j.cell.2021.05.004. Epub 2021 Jun 8.